King International Investment Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

King International Investment heeft een totaal eigen vermogen van HK$266.0M en een totale schuld van HK$2.5M, wat de schuld-eigenvermogensverhouding op 0.9% brengt. De totale activa en totale passiva bedragen respectievelijk HK$336.1M en HK$70.1M. De EBIT King International Investment is HK$17.6M waardoor de rentedekking 88.6 is. Het heeft contanten en kortetermijnbeleggingen van HK$473.0K.

Belangrijke informatie

0.9%

Verhouding schuld/eigen vermogen

HK$2.50m

Schuld

Rente dekkingsratio	88.6x
Contant	HK$473.00k
Aandelen	HK$266.05m
Totaal verplichtingen	HK$70.09m
Totaal activa	HK$336.13m

Recente financiële gezondheidsupdates

Recent updates

King International Investment Limited (HKG:928) Might Not Be As Mispriced As It Looks After Plunging 26%

Oct 16

There's Been No Shortage Of Growth Recently For King International Investment's (HKG:928) Returns On Capital

Oct 15

King International Investment Limited (HKG:928) Soars 32% But It's A Story Of Risk Vs Reward

Aug 22

King International Investment's (HKG:928) Performance Raises Some Questions

Aug 07

King International Investment Limited (HKG:928) Might Not Be As Mispriced As It Looks After Plunging 26%

Dec 21

Benign Growth For Life Healthcare Group Limited (HKG:928) Underpins Stock's 43% Plummet

Jul 13

Life Healthcare Group (HKG:928) Is Looking To Continue Growing Its Returns On Capital

Oct 28

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( HK$330.7M ) 928 } overtreffen de korte termijn passiva ( HK$67.7M ).

Langlopende schulden: De kortetermijnactiva 928 ( HK$330.7M ) overtreffen de langetermijnschulden ( HK$2.4M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 0.8% ) 928 wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 928 is de afgelopen 5 jaar gestegen van 0% naar 0.9%.

Schuldendekking: De operationele kasstroom van 928 is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: De rentebetalingen op de schuld van 928 worden goed gedekt door EBIT ( 88.6 x dekking).

King International Investment Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Life Healthcare Group to Be Deleted from Other OTC

Recent updates

King International Investment Limited to Report First Half, 2025 Results on Nov 29, 2024

New major risk - Share price stability

King International Investment Limited (HKG:928) Might Not Be As Mispriced As It Looks After Plunging 26%

There's Been No Shortage Of Growth Recently For King International Investment's (HKG:928) Returns On Capital

King International Investment Limited Announces Board and Committee Changes

King International Investment Limited, Annual General Meeting, Sep 13, 2024

King International Investment Limited (HKG:928) Soars 32% But It's A Story Of Risk Vs Reward

New major risk - Share price stability

King International Investment's (HKG:928) Performance Raises Some Questions

Full year 2024 earnings released: EPS: HK$0.01 (vs HK$0.017 loss in FY 2023)

New minor risk - Share price stability

Full year 2024 earnings released: EPS: HK$0.01 (vs HK$0.017 loss in FY 2023)

King International Investment Limited to Report Fiscal Year 2024 Results on Jun 28, 2024

King International Investment Limited Announces Change of Joint Company Secretary Andauthorised Representative

New major risk - Market cap size

King International Investment Limited Announces Redesignation of Co Chairman of Wang Mengyao as Chairman

King International Investment Limited Announces Management Changes

King International Investment Limited (HKG:928) Might Not Be As Mispriced As It Looks After Plunging 26%

King International Investment Limited Announces Executive Changes

Life Healthcare Group Limited announced that it has received HKD 9.6288 million in funding

First half 2024 earnings released: EPS: HK$0.001 (vs HK$0.001 loss in 1H 2023)

Life Healthcare Group Limited announced that it expects to receive HKD 9.6288 million in funding

Life Healthcare Group Limited announced that it expects to receive HKD 9.6288 million in funding

Life Healthcare Group Limited to Report First Half, 2024 Results on Nov 30, 2023

Life Healthcare Group Limited, Annual General Meeting, Sep 29, 2023

Life Healthcare Group Limited Announces Management Changes

Life Healthcare Group Limited Announces Board Changes

Life Healthcare Group Limited Announces Chief Executive Officer Changes

New major risk - Share price stability

Life Healthcare Group Limited Announces Resignation of Mr. Huang Zhifang as Executive Director

Benign Growth For Life Healthcare Group Limited (HKG:928) Underpins Stock's 43% Plummet

New major risk - Market cap size

New minor risk - Share price stability

Full year 2023 earnings released: HK$0.017 loss per share (vs HK$0.027 loss in FY 2022)

Life Healthcare Group Limited to Report Fiscal Year 2023 Results on Jun 30, 2023

New minor risk - Financial data availability

First half 2023 earnings released: HK$0.001 loss per share (vs HK$0.004 loss in 1H 2022)

High number of new and inexperienced directors

Life Healthcare Group Limited to Report Q2, 2023 Results on Nov 28, 2022

Life Healthcare Group Limited Announces Board Changes

Full year 2022 earnings released: HK$0.024 loss per share (vs HK$0.004 loss in FY 2021)

Life Healthcare Group Limited, Annual General Meeting, Oct 12, 2022

Less than half of directors are independent

Life Healthcare Group Limited Appoints Yuan Limin as Executive Director

Life Healthcare Group Limited to Report Fiscal Year 2022 Final Results on Aug 31, 2022

Insider recently bought HK$27m worth of stock

Full year 2022 earnings released: HK$0.024 loss per share (vs HK$0.004 loss in FY 2021)

Life Healthcare Group Limited to Report Fiscal Year 2022 Results on Jun 30, 2022

Life Healthcare Group Limited Appoints Huang Zhifang as Executive Director

Life Healthcare Group Limited Announces Executive Changes

Life Healthcare Group Limited (SEHK:928) entered into a memorandum of understanding to acquire Earn Wealth Group Holdings Limited from Liu Zhiwei.

High number of new directors

Independent Non-Executive Director Chun Man Cheng has left the company

Life Healthcare Group (HKG:928) Is Looking To Continue Growing Its Returns On Capital

Independent Non Executive Director Xin Zheng has left the company

Full year 2021 earnings released: HK$0.004 loss per share (vs HK$0.023 loss in FY 2020)

Life Healthcare Group Limited Provides Unaudited Earnings Guidance for the Year Ended March 31, 2021

Life Healthcare Group Limited's Wholly-Owned Subsidiary LHCS Enters into the Joint Venture Agreement

Insider recently bought HK$7.5m worth of stock

Life Healthcare Group Limited Announces Resignation of Shan Hua as Non-Executive Director

Life Healthcare Group Limited to Report First Half, 2021 Results on Nov 27, 2020

Life Healthcare Group Limited Announces Resignation of Mr. Yang Zhiying as an Executive Director

Life Healthcare Group to Be Deleted from Other OTC

Life Healthcare Group Limited has completed a Follow-on Equity Offering in the amount of HKD 29.98352 million.

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven